We welcome many abstract submissions from overseas.
Period for Abstract Submission
Abstract submission has been closed
Thank you for your submission.
Travel Grant
Travel Grant application has been closed.
A Travel Grant is provided to the first author.
Please refer to the information below regarding the amount.
Please note that the first author must give a presentation at the Joint Meeting of the 30th Annual Meeting of the Japanese Heart Rhythm Society and the 32nd Annual Scientific Meeting of the Japanese Society of Electrocardiology in Kyoto on the accepted abstract.
Moreover, even if more than one abstract is accepted, the travel grant will be provided for only one abstract.
From Southeast Asian Countries (Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, and Vietnam) 100,000 JPY |
From Nearby Asian Countries (China, Hong Kong, Taiwan, and Korea) 50,000 JPY |
From Other Countries 100,000 JPY |
*Applicant must be the first author and presenter of the submitted abstract.
*No age limitation.
*Deadline for application is February 25, 2015.
Abstract Submission Process
All abstracts for General Presentation, Symposium and Panel Discussion must be written in English.
Presentation Style/Theme | Presentation Language | |
---|---|---|
General Presentation | Japanese/ English |
|
Symposium | Inherited Arrhythmias- Bench to Bedside | English |
Symposium | Sleep Apnea Syndrome and Arrhythmias -Relations with the Autonomic Nervous System- | English |
Symposium | Various Methods of PV Isolation, the Differences and Influence on Prognosis | Japanese |
Symposium | Risk Stratification of Early Repolarization Syndrome | English |
Symposium | Patient Management of Pain and Anxiety during Electrophysiological Procedures as Device Implantation or Catheter Ablation | Japanese |
Symposium | Noninvasive Test for Prediction of Sudden Cardiac Death -Conventional Methods and its New Application- | English |
Symposium | Balloon technology for AF ablation -current status and future perspective- | Japanese |
Symposium | Progress of research on the QT prolongation | English |
Symposium | Approach to Non-responder of CRT | English |
Symposium | Sinoatrial Node Pacemaker Clocks・・・The Mechanism of Heart Beats | English |
Symposium | Therapeutic Strategy for Ventricular Tachycardia. - ”The New Concepts”- |
Japanese |
Symposium | Resolution of the Mechanism of Atrial Fibrillation and its Application Rotor Mapping its Theory and Reality |
English |
Panel Discussion | Risk Stratification of Syncope | English |
Panel Discussion | Total Management of Catheter Ablation for Persistent Atrial Fibrillation | Japanese |
Panel Discussion | Management for frequent ICD therapy | Japanese |
Panel Discussion | The role of imaging modalities in the EP laboratory | Japanese |
Topics Designated by the JSE Academic Committee | Topics Designated by the JSE Academic Committee | Japanese |
During the submission process, all authors will be required to provide membership number for either the Japanese Heart Rhythm Society (JHRS) or the Japanese Society of Electrophysiology (JSE). However, overseas applicants should choose "From Abroad" botton and enter "99" as a membership number.
The societies welcome membership outside of Japan.
If you forgot or lost your membership number, please inquire at the JHRS or the JSE secretariat office via fax or email.
The body of the abstract (excluding title, author name(s) and organizational affiliation(s)) must be 250 words or less in English. It may include one diagram, which should be in GIF or JPEG format and of 300 KB or less in size. The diagram can be in either landscape or portrait orientation and will be reduced to about 75 mm x 45 mm when printed. Please note that even if you submit a color diagram, it will be printed in black and white. In case the abstract includes a diagram, the body of the abstract should be 150 words or less.
In the case of symposium and panel discussion proposals, the author must submit an abstract written in English for the proceeding as well as one for the selection process, which should be no more than 500 words. Note that the diagrams for a symposium and panel discussion proposal cannot be registered via the online submission system. Please submit them separately to the JHRS secretariat office via email or postal mail, to arrive by February 12. When you do so, please identify the figures or images with your registration number.
The Japanese Heart Rhythm Society 2-5 KiyoTokyo Build 6F, Kandaogawamachi, Chiyoda-ku, Tokyo 101-0052, Japan Email: office@jhrs.or.jp
Upon your abstract registration, you will automatically be assigned a registration number. With this number and your own password, you will be able to access and revise your registered abstracts as many times as you wish, up until the noon of February 12, 2015.
You will be responsible for the safekeeping of your password and other confidential information. We strongly urge that you keep a note of your registration number and password, as you will need them to confirm receipt of your abstract and revise your submission. Please note that, for security reasons, if you lose or forget your password or registration number we will be unable to provide them to you under any circumstances.
Please select your presentation language, either “Japanese or English” or “Japanese preferred” at the time of registration. Note that all slides and posters must be in English only.
Please select your presentation style, either “oral or poster” or “poster preferred” at the time of registration.
The presentation language will, in principle, be as per your indication. The presentation style (oral or poster), however, will be determined by the congress secretariat with regard to the schedule.
Accepted abstracts will be published in the proceeding in which abstract title, text, author's name and organizational affiliation will be printed exactly as you registered on the website. We recommend you to carefully read the instructions on this website before filling out required information upon submitting your abstract.
Requirements
The first author and co-author(s) must be members of the Japanese Heart Rhythm Society or the Japanese Society of Electrocardiology, and must have paid the 2014 membership dues.
If you are not a member of the either societies, the membership application form is available on the JHRS or JSE website. Please download the form and complete the application process.
Non-Japanese nationals do not require the memberships of the societies.
Abstract Registration
Please click the “Registration” button at the bottom of this page to access the registration page. The registration starts from the middle of December, 2014 until February 20, 2015.
※Abstract submission has been closed.
As part of the registration process, you will be requested to identify the category of your abstract by entering a category number. Please select from the following list the number that best describes the subject of your abstract.
1 | AF: Ablation |
---|---|
2 | AF: Case Reports |
3 | AF: Clinical Studies |
4 | AF: New Mapping & Imaging Techniques |
5 | AF: Others |
6 | AF: Pharmacotherapy |
7 | AF: Surgical Methods |
8 | AFL/AT: Ablation |
9 | AFL/AT: Case Reports |
10 | AFL/AT: Clinical Studies |
11 | AFL/AT: New Mapping & Imaging Techniques |
12 | AFL/AT: Othres |
13 | AFL/AT: Pharmacotherapy |
14 | Autonomic tone basic |
15 | Autonomic tone clinical |
16 | Bradycardia Devices: Case Reports |
17 | Bradycardia Devices: Clinical Studies |
18 | Bradycardia Devices: Device Technologies and Techniques |
19 | Bradycardia Devices: Indications and Complications |
20 | Bradycardia Devices: Others |
21 | Bradycardia: Clinical Studies |
22 | Cell Biology, Physiology and Pharmacology |
23 | Computer Modeling/Simulation |
24 | Congenital Heart Disease: Medical and Surgical Approches |
25 | Development and Regeneration (including iPS cells) |
26 | Diagnostic Devices & Sensors: Clinical Studies |
27 | Diagnostic Devices & Sensors: Experimental Studies |
28 | Electrocardiographic Assessment: Methods and Outcome |
29 | Experimental studies: AF |
30 | Experimental studies:Others |
31 | Experimental studies:VT/VF |
32 | Genomics: Bedside |
33 | Genomics: Bench |
34 | Heart Failure Devices: Case Reports |
35 | Heart Failure Devices: Clinical Studies |
36 | Heart Failure Devices: Indications and Complications |
37 | Heart Failure Devices: Others |
38 | Imaging Methodologies: CT/MRI/Others |
39 | Inherited Disorder: Brugada syndrome, ERS and Idiopathic VF |
---|---|
40 | Inherited Disorder: Long QT syndrome, ARVC, and Others |
41 | Ion Channels and Transporters |
42 | Leads & Electrodes: Clinical Studies |
43 | Leads & Electrodes: Extraction/Removal |
44 | Leads & Electrodes: Implantation and Complications |
45 | Leads & Electrodes: Others |
46 | Leads & Electrodes: Technologies and Techniques |
47 | Pediatric Cardiology: Ablation and Devices |
48 | Pediatric Cardiology: Clinical Studies |
49 | Perioperative Management |
50 | Reimbursement, Regulation and Health Policy |
51 | Remote Monitorring system |
52 | Risk Assessment: Holter ECG/Heart Rate Variability/QT Interval |
53 | Risk Assessment: Other Methods |
54 | Risk Assessment: Signal Average ECG/T-Wave Alternans |
55 | Sudden Cardiac Death: Epidemiology and Etiology |
56 | Sudden Cardiac Death: Prevention and Treatment |
57 | Surgical Techniques and Treatment |
58 | SVT/AVNRT/WPW: Ablation |
59 | SVT/AVNRT/WPW: Case Reports |
60 | SVT/AVNRT/WPW: Clinical Studies |
61 | SVT/AVNRT/WPW: Others |
62 | SVT/AVNRT/WPW: Pharmacotherapy |
63 | Syncope: Clinical Studies |
64 | Syncope: Othres |
65 | Syncope: Pharmacothepy and Devices |
66 | Syncope: Tilt Table Testing |
67 | Tachycardia Devices: Case Reports |
68 | Tachycardia Devices: Clinical Studies |
69 | Tachycardia Devices: Indications and Complications |
70 | Tachycardia Devices: Othres |
71 | VT & VF: Ablation |
72 | VT & VF: Case Reports |
73 | VT & VF: Clinical Studies |
74 | VT & VF: Others |
75 | VT & VF: Pharmacotherapy |
If you are applying for a general presentation, please indicate whether or not you would like your abstract to be forwarded to the YIA selection process. The final nominees will be selected based on peer-review recommendation. Those finalists will make a presentation for the final selection at the YIA session during the congress.
‹‹Eligibility››
Inquiries